< Back to all Breaking News
BVXV
10/23/2020 10:10am
BiondVax says Phase 3 trial of M-001 failed to meet efficacy endpoints 
Don't miss out!
We read the Wall Street research, SEC filings and press releases so you don't have to.
Sign up for our 14-day free trial to read this story.
